SWTX logo

SpringWorks Therapeutics (SWTX) Selling, general & administrative expenses

annual SGA:

$256.65M+$59.10M(+29.92%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual SGA is $256.65 million, with the most recent change of +$59.10 million (+29.92%) on December 31, 2024.
  • During the last 3 years, SWTX annual SGA has risen by +$184.86 million (+257.49%).
  • SWTX annual SGA is now at all-time high.

Performance

SWTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

quarterly SGA:

$76.50M-$598.00K(-0.78%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly SGA is $76.50 million, with the most recent change of -$598.00 thousand (-0.78%) on March 31, 2025.
  • Over the past year, SWTX quarterly SGA has increased by +$16.39 million (+27.26%).
  • SWTX quarterly SGA is now -0.78% below its all-time high of $77.10 million, reached on December 31, 2024.

Performance

SWTX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

TTM SGA:

-$4.49B-$253.93M(-6.00%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM SGA is -$4.49 billion, with the most recent change of -$253.93 million (-6.00%) on March 31, 2025.
  • Over the past year, SWTX TTM SGA has dropped by -$4.70 billion (-2202.09%).
  • SWTX TTM SGA is now -19888.08% below its all-time high of -$22.45 million.

Performance

SWTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

SWTX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.9%+27.3%-2202.1%
3 y3 years+257.5%+179.6%-5271.6%
5 y5 years+1437.4%+1094.8%-10000.0%

SWTX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+257.5%-0.8%+146.9%-243.5%at low
5 y5-yearat high+1437.4%-0.8%+1012.9%-1275.0%at low
alltimeall timeat high+2886.8%-0.8%+4094.1%<-9999.0%at low

SWTX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$76.50M(-0.8%)
$273.04M(+6.4%)
Dec 2024
$256.65M(+29.9%)
$77.10M(+25.2%)
$256.65M(+7.2%)
Sep 2024
-
$61.60M(+6.5%)
$239.39M(+6.7%)
Jun 2024
-
$57.84M(-3.8%)
$224.33M(+5.1%)
Mar 2024
-
$60.11M(+0.5%)
$213.49M(+8.1%)
Dec 2023
$197.55M(+46.8%)
$59.84M(+28.6%)
$197.55M(+10.8%)
Sep 2023
-
$46.55M(-1.0%)
$178.24M(+6.5%)
Jun 2023
-
$46.99M(+6.4%)
$167.37M(+10.6%)
Mar 2023
-
$44.17M(+9.0%)
$151.36M(+12.5%)
Dec 2022
$134.55M(+87.4%)
$40.53M(+13.6%)
$134.55M(+11.7%)
Sep 2022
-
$35.67M(+15.1%)
$120.48M(+17.2%)
Jun 2022
-
$30.99M(+13.2%)
$102.83M(+18.5%)
Mar 2022
-
$27.37M(+3.5%)
$86.78M(+20.9%)
DateAnnualQuarterlyTTM
Dec 2021
$71.79M(+143.7%)
$26.45M(+46.7%)
$71.79M(+33.3%)
Sep 2021
-
$18.03M(+20.8%)
$53.86M(+23.8%)
Jun 2021
-
$14.93M(+20.6%)
$43.50M(+22.7%)
Mar 2021
-
$12.38M(+45.3%)
$35.44M(+20.3%)
Dec 2020
$29.46M(+76.5%)
$8.52M(+11.1%)
$29.46M(+12.7%)
Sep 2020
-
$7.67M(+11.6%)
$26.14M(+13.4%)
Jun 2020
-
$6.87M(+7.4%)
$23.06M(+16.3%)
Mar 2020
-
$6.40M(+23.2%)
$19.83M(+18.8%)
Dec 2019
$16.69M(+94.3%)
$5.20M(+13.4%)
$16.69M(+17.3%)
Sep 2019
-
$4.58M(+25.7%)
$14.24M(+24.1%)
Jun 2019
-
$3.65M(+11.7%)
$11.48M(+46.6%)
Mar 2019
-
$3.27M(+19.1%)
$7.83M(+71.5%)
Dec 2018
$8.59M
$2.74M(+50.3%)
$4.57M(+150.3%)
Sep 2018
-
$1.82M
$1.82M

FAQ

  • What is SpringWorks Therapeutics annual SGA?
  • What is the all time high annual SGA for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual SGA year-on-year change?
  • What is SpringWorks Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly SGA year-on-year change?
  • What is SpringWorks Therapeutics TTM SGA?
  • What is the all time high TTM SGA for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM SGA year-on-year change?

What is SpringWorks Therapeutics annual SGA?

The current annual SGA of SWTX is $256.65M

What is the all time high annual SGA for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual SGA is $256.65M

What is SpringWorks Therapeutics annual SGA year-on-year change?

Over the past year, SWTX annual SGA has changed by +$59.10M (+29.92%)

What is SpringWorks Therapeutics quarterly SGA?

The current quarterly SGA of SWTX is $76.50M

What is the all time high quarterly SGA for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly SGA is $77.10M

What is SpringWorks Therapeutics quarterly SGA year-on-year change?

Over the past year, SWTX quarterly SGA has changed by +$16.39M (+27.26%)

What is SpringWorks Therapeutics TTM SGA?

The current TTM SGA of SWTX is -$4.49B

What is the all time high TTM SGA for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM SGA is -$22.45M

What is SpringWorks Therapeutics TTM SGA year-on-year change?

Over the past year, SWTX TTM SGA has changed by -$4.70B (-2202.09%)
On this page